InvestorsHub Logo
Followers 826
Posts 119431
Boards Moderated 16
Alias Born 09/05/2002

Re: DewDiligence post# 999

Monday, 11/29/2021 10:12:44 AM

Monday, November 29, 2021 10:12:44 AM

Post# of 1162
Deucravacitinib for psoriasis has 9/10/22 PDUFA date (with standard FDA review):

https://www.businesswire.com/news/home/20211129005192/en

The Deucra MAA in psoriasis has also been validated by the EMA.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News